Densa Pharma Private Limited
About Densa Pharma Private Limited
Data last updated:
Densa Pharma Private Limited is a private limited company based in Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 21 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2020PTC374788.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sushma Mishra and Sanatan Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No. S – 48 Gali No – 3 Mithila Vihar Prem Nagar – 2 Kirari Suleman Nagar, Delhi, India – 110086.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressH.No. S – 48 Gali No – 3 Mithila Vihar Prem Nagar – 2 Kirari Suleman Nagar, Delhi, India – 110086
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Densa Pharma Private Limited FY 2025 filings available
Densa Pharma Private Limited reported revenue of ₹500 (down 38% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Densa Pharma Private Limited
Revenue fell 38% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Densa Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Densa Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Densa Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Densa Pharma Private Limited
Densa Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushma Mishra | Director | 21 Dec 2020 | 5 Years 9 Months | Current |
| Sanatan Kumar Mishra | Director | 21 Dec 2020 | 5 Years 9 Months | Current |
Charges & Borrowings of Densa Pharma Private Limited
Densa Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Densa Pharma Private Limited
Employment history and EPFO contributions of people linked to Densa Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Densa Pharma Private Limited
Densa Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Sanatan Kumar Mishra was appointed as Director on 21 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Densa Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Densa Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Densa Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Densa Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Densa Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Densa Pharma Private Limited
Densa Pharma is an active private limited company based in Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 21 December 2020 (6+ years old) and is registered under CIN U24299DL2020PTC374788.
Densa Pharma has 2 current directors:
- Sushma Mishra - Director
- Sanatan Kumar Mishra - Director
The CIN (Corporate Identification Number) of Densa Pharma is U24299DL2020PTC374788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Densa Pharma was incorporated on 21 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Sanatan Kumar Mishra was appointed as Director on 21 Dec 2020. Sushma Mishra was appointed as Director on 21 Dec 2020.
The registered office of Densa Pharma is at H.No. S – 48 Gali No – 3 Mithila Vihar Prem Nagar – 2 Kirari Suleman Nagar, Delhi, India – 110086.
Densa Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Densa Pharma operates in the chemicals industry, in the fine chemicals and other chemical products segment.
No. Densa Pharma is not listed on any stock exchange. It is an unlisted company.
Densa Pharma can be reached at its registered office: H.No. S – 48 Gali No – 3 Mithila Vihar Prem Nagar – 2 Kirari Suleman Nagar, Delhi, India – 110086.